Okuyama A - Search Results

1

Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis.

Permpongkosol S, Wang JD, Takahara S, Matsumiya K, Nonomura N, Nishimura K, Tsujimura A, Kongkanand A, Okuyama A. Permpongkosol S, et al. Among authors: okuyama a. Int J Cancer. 2002 Mar 10;98(2):167-72. doi: 10.1002/ijc.10178. Int J Cancer. 2002. PMID: 11857403

2

Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models.

Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, Morimoto J, Fukui R, Hoshiga M, Ishihara T, Nonomura N, Suzuki S, Okuyama A, Katsuoka Y. Azuma H, et al. Among authors: okuyama a. Cancer Res. 2002 Mar 1;62(5):1410-9. Cancer Res. 2002. PMID: 11888913

3

Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells.

Nishimura K, Matsumiya K, Miura H, Tsujimura A, Nonomura N, Matsumoto K, Nakamura T, Okuyama A. Nishimura K, et al. Among authors: okuyama a. Int J Androl. 2003 Jun;26(3):175-9. doi: 10.1046/j.1365-2605.2003.00413.x. Int J Androl. 2003. PMID: 12755996

4

Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation.

Wang JD, Takahara S, Nonomura N, Ichimaru N, Toki K, Azuma H, Matsumiya K, Okuyama A, Suzuki S. Wang JD, et al. Among authors: okuyama a. Prostate. 1999 Jun 15;40(1):50-5. doi: 10.1002/(sici)1097-0045(19990615)40:1<50::aid-pros6>3.0.co;2-n. Prostate. 1999. PMID: 10344723

5

The clinical studies of sildenafil for the ageing male.

Tsujimura A, Yamanaka M, Takahashi T, Miura H, Nishimura K, Koga M, Iwasa A, Takeyama M, Matsumiya K, Takahara S, Okuyama A. Tsujimura A, et al. Among authors: okuyama a. Int J Androl. 2002 Feb;25(1):28-33. doi: 10.1046/j.1365-2605.2002.00320.x. Int J Androl. 2002. PMID: 11869374 Clinical Trial.

6

A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine.

Tanaka T, Takahara S, Hatori M, Suzuki K, Wang J, Ichimaru N, Suzuki S, Morozumi K, Okuyama A, Yamanaka H. Tanaka T, et al. Among authors: okuyama a. Cancer Lett. 2002 Jul 26;181(2):165-71. doi: 10.1016/s0304-3835(01)00799-6. Cancer Lett. 2002. PMID: 12175531

7

Analysis of Fas gene mutations on laser capture microdissected specimens from renal cell carcinoma.

Takayama H, Takakuwa T, Tsujimoto Y, Nonomura N, Okuyama A, Aozasa K. Takayama H, et al. Among authors: okuyama a. Jpn J Cancer Res. 2002 Nov;93(11):1201-6. doi: 10.1111/j.1349-7006.2002.tb01224.x. Jpn J Cancer Res. 2002. PMID: 12460460 Free PMC article.

8

[Therapy for hormone-refractory prostate cancer].

Nishimura K, Takahara S, Nonomura N, Okuyama A. Nishimura K, et al. Among authors: okuyama a. Nihon Rinsho. 2002 Dec;60 Suppl 11:266-71. Nihon Rinsho. 2002. PMID: 12599583 Review. Japanese. No abstract available.

9

Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity.

Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, Gotoh R, Okuyama A, Suzuki S, Katsuoka Y, Takahara S. Azuma H, et al. Among authors: okuyama a. Anticancer Res. 2003 Jul-Aug;23(4):3183-93. Anticancer Res. 2003. PMID: 12926052

10

Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.

Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. Nishimura K, et al. Among authors: okuyama a. Cancer Res. 2003 Aug 15;63(16):4888-94. Cancer Res. 2003. PMID: 12941811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters